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Abstract  
We used water-soluble Chitosan obtained by Maillard reaction with glucosamine to 
microencapsulate soy genistein (Ge) and preserve its biological activity for oral 
administration. Release of Ge was pH dependent with a super Case II mechanism at pH 
1.2 and an anomalous transport with non-Fickian kinetics at pH 6.8. Microencapsulated 
Ge retained its antioxidant properties in vitro and its daily administration to mice 
attenuated clinical signs of acute colitis, limited inflammatory reaction and reduced 
oxidative stress and tissue injury as well. Remarkably, after feeding microencapsulated 
Ge the production of IL-10 in colonic tissue was restored to levels of untreated controls. 
According to statistical multivariate analysis, this cytokine was the parameter with the 
highest influence on the inflammatory/oxidative status. Microencapsulation of Ge with 
derivatized Chitosan becomes an interesting alternative to develop therapeutic 
approaches for oxidative inflammatory diseases; our findings suggest that the soy 
isoflavone could be incorporated into any functional food for application in intestinal 
inflammation.  
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1. Introduction  
In biological systems, production of reactive oxygen (ROS) and nitrogen (RNS) species 
is common and physiological scavenging activity keeps the balance between oxidation 
and antioxidation [1]. Excess of ROS and RNS may saturate the antioxidant machinery 
leading to chronic injury as described in inflammatory bowel diseases (IBD), where 
pro-inflammatory cytokines and oxidative reactions affect the redox equilibrium within 
the gut mucosa [1-3]. Accordingly, both IBD patients and mice with intestinal 
inflammation show higher levels of ROS in mucosal tissues [4]. Thus, the development 
of antioxidant strategies to restore intestinal homeostasis is critical and nowadays, 
therapeutic alternatives with biologic agents that either stimulate local production of 
anti-inflammatory molecules or affect the redox balance are intensely evaluated [3]. 
Flavonoids are natural compounds with phenolic groups that can accept electrons to 
form phenoxyl radicals, disrupting oxidation reactions in cellular components [5]. 
Among them, genistein (Ge), a phytoestrogen found primarily in soy products, has 
received wide attention due to its many biological activity such as binding to estrogen 
receptors [6], inhibition of tyrosine kinases [7], activation of endothelial nitric oxide 
synthase (eNOS), and production of defensins [8,9]. Moreover, it has been shown that 
the intake of 600 mg/kg Ge reduces inflammation, downregulates cytokine expression 
and improves colonic permeability in mice challenged with dextran sulfate sodium 
(DSS) [10], supporting an effective modulatory activity of Ge in intestinal mucosa.  
 
Flavonoids in foods of natural origin are found as esters, glycosides or polymers that 
become partially hydrolyzed by the microbiota in the intestinal lumen, producing 
substances of smaller size less active and reducing the absorption efficiency. 
Additionally, flavonoids and other natural bioactive compounds are chemically 
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unstable, and susceptible to oxidative degradation particularly when exposed to oxygen, 
light, moisture, heat, and food processing conditions that may also affect their 
nutraceutical value [11-13]. Encapsulation systems as carriers of bioactive compounds 
can be useful tools to preserve their biological activity for oral administration [14].  
Microencapsulation and nanoencapsulation are two important technological alternatives 
with several advantages to improve the functionality of the products. Most of the 
materials used for encapsulation are polymers of carbohydrates, proteins, lipids and 
other organic and inorganic materials that must be approved as "generally recognized as 
harmless" (GRAS) materials [15]. Several traditional techniques such as spray drying, 
freeze drying, extrusion, electrospinning, and coacervation are standard for 
encapsulating bioactive compounds [16], and recently, there has been growing interest 
in nanoscale delivery systems for bioactive compounds such as nanoparticles of 
biopolymers, nanohydrogels, neosomes, bilosomes, phytosomes, nanofibers, and 
flower-like porous lactose particles [17]. Specifically, for oral delivery of anti-
inflammatory drugs, nanocarriers of functionalized mesoporous silica or multi-
laminated metal hydroxide have been designed [18,19]. Herein, to preserve the 
antioxidant potential of Ge, we prepared microcapsules (MCs) with glucosamine water-
soluble Chitosan derivative (WSChitosan) [20] by spray drying, a technique widely 
used due to its low cost that offer the possibility of continuous production of tailor-
made particles for specific functions and needs of food industry [21]. Our findings show 
that microencapsulated Ge maintained its antioxidant properties in vitro. The daily oral 
administration of Ge using this delivery system blocked the inflammatory reaction in 
DSS colitis, limiting both tissue injury and oxidative stress. Remarkably, the flavonoid 
restored the production of IL-10, a critical mediator of the mucosal homeostasis. 
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2. Materials and Methods 
2.1. Reagents 
Chitosan MW 583 kDa (78% deacetylated), glucosamine hydrochloride (GAHC), 
nitrotetrazolium blue chloride (NBT), hydroxylamine hydrochloride (HAHC), 2-Deoxy-
D-ribose (DoR), methionine, riboflavin, trichloroacetic acid (TCA), p-nitrophenyl-2-
acetamido-β-glucopyranoside, citric acid, hexadecyl trimethyl ammonium bromide, 
sodium tripolyphosphate (TPP), aglycone Genistein (Ge) and fluorescein isothiocyanate 
(FITC) were obtained from Sigma-Aldrich (MO). Thiobarbituric acid (TBA) and 
ethylenediaminetetraacetic (EDTA) were provided by Merck (Germany); monobasic 
potassium phosphate (KH2PO4), sodium chloride (NaCl), sodium hydroxide (NaOH), 
potassium chloride (KCl), sodium bicarbonate (NaHCO3), ascorbic acid, hydrogen 
peroxide (H2O2), hydrochloride acid (HCl), ferric chloride (FeCl3), and glacial acetic 
acid (CH3COOH) were from Cicarelli (Argentina). Dimethyl sulfoxide (DMSO) was 
from Biopack (Argentina). Bradford reagent was from Bio-Rad (USA) and 3,3',5,5' 
tetramethylbenzidine (TMB) was provided by BD Biosciences (USA). Dextran sulfate 
sodium (DSS) was kindly provided by Dextran Products Limited (Canada). Aqueous 
solutions were prepared with ultrapure water. 
 
2.2. Mice 
Six- to eight-week-old female C57BL/6 (B6) mice were used in these studies. Animals 
were maintained in specific pathogen-free conditions, housed in collective cages at 22 ± 
1°C under a 12-h light/dark cycle (lights on at 7:00 a.m.) with free access to laboratory 
chow and drinking water. Animal experiments were approved by and conducted in 
accordance with guidelines of the Committee for Animal Care and Use of the Facultad 
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de Ciencias Químicas, Universidad Nacional de Córdoba (Approval N
o
 HCD 15-09-
69596). Our animal facility obtained NIH animal welfare assurance (Assurance N
o
 
A5802-01, Office of Laboratory Animal Welfare, NIH, Bethesda, MD, USA). 
 
2.3. Preparation of water-soluble Chitosan derivative by Maillard reaction 
Water-soluble derivatized Chitosan (WSChitosan) was obtained by Maillard reaction 
between Chitosan with glucosamine hydrochloride as described by Vanden Braber et al. 
[20].  
 
2.4. Spray-Drying microencapsulation of Ge in WSChitosan 
Microcapsules (MCs) with Ge were obtained as described by Vanden Braber et al. [22]. 
Ge was added to the shell material solution at 5% (w/w) of the biopolymer. Working 
conditions such as inlet temperature, liquid flow, aspiration rate and compressed spray 
air flow were set at 130 °C, 4 mL/min, 100% and 0.67 m
3
/h, respectively. Empty MCs 
were prepared without Ge in the mixture to dry. Powders obtained after spray-drying 
were stored at -20 °C until analyzed. 
 
2.5. Microencapsulation Efficiency 
Microencapsulation efficiency (ME) was analyzed as described by Vanden Braber et al. 
[22]. To determine Ge content, we evaluated absorbance at 262 nm; ME, defined as 
percentage of Ge molecules in the core in relation to its total (core + surface) 
concentration, was calculated using equation (1) [23]. 
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 (1) 
where [Ge]I and [Ge]T are the Ge concentration inside and total in MCs, respectively; 
inner content was calculated by subtracting the total and outer content. 
 
2.6. MCs morphology  
Morphology and size distribution of spray-dried MCs were evaluated by scanning 
electronic microscopy (SEM) with a ZEISS SIGMA VP Field Emission Scanning 
Electron Microscope (FE-SEM) (ZEISS, Germany), using an acceleration voltage of 5 
kV. MCs were fixed in stubs containing a double-faced adhesive metallic tape and 
coated with gold in a CED 010 vacuum evaporator (Balzers Union, Liechtenstein). 
 
2.7. Release assays in simulated gastrointestinal digestion conditions 
Ge release was studied for 48 h to simulate extended release in gastrointestinal 
conditions using an orbital shaker at a rotational speed of 150 rpm and 37°C as 
previously described [24,25]. We used 125 mM NaCl, 7mM KCl, 45 mM NaHCO3, 0.1 
N HCl at pH 1.2 to simulate the gastric fluid conditions (first 2.5 h) and 50 mM 
KH2PO4; 22.4 mM NaOH at pH 6.8 to simulate intestinal fluid conditions (the rest of 
the assay time).  
Release profiles were fitted according to the mathematical model of Korsmeyer-Peppas 
equation (2) [26]. 
         
(2) 
          
  (%) [ ] [ ] 100 I TME Ge Ge

 nt K
Ge
K t
Ge
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In this equation, Get/Ge is the fraction of Ge released at time t, KK is the Korsmeyer-
Peppas constant that incorporates structural and geometric characteristics, and n is a 
diffusional exponent that depends on the release mechanism and geometry of the tested 
system. 
 
2.8. Hydroxyl radical scavenging activity assay 
Hydroxyl radical (HO

) scavenging effect of MCs with Ge, empty MCs and pure Ge 
was determined as described [27]; the colored adduct was measured at 532 nm and the 
% of scavenging activity (SA) was calculated with equation (3): 
 X 0 SA (%)  = 1 100A A   (3) 
A0 is the absorbance of the control and AX is the absorbance with MCs samples.  
Trolox was used as antioxidant reference. The trolox equivalent activity (TEAC) was 
determined using a standard curve. 
 
2.9. Superoxide radical scavenging activity assay  
Scavenging of superoxide radical (O2
−
) of MCs with Ge, empty MCs and pure Ge was 
performed as described [27]; reduced NBT was measured at 560 nm and scavenging 
activity of O2
− 
was calculated with equation 3. 
 
2.10. Biodisponibility studies 
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For biodisponibility studies, empty MCs were labeled with FITC as previously [28];  
C57BL/6 mice were fed 200 L empty MCs-FITC in 0.25% (v/v) acetic acid and 4-6 h 
later, duodenum, jejunum, ileum and colon from identical anatomical positions were 
removed; luminal content of each section was collected and centrifuged at 1,000 rpm; 
supernatants were used by flow cytometry; 100,000 fluorescent events were acquired on 
a FACSCanto (BD Pharmingen) and analyzed using FlowJo software (Tree Star, Inc.). 
As fluorescence negative controls, mice received unlabeled empty MCs in 0.25% (v/v) 
acetic acid. 
 
2.11. Induction and assessment of experimental colitis 
The DSS model is a robust, well established model that has been used to screen 
potential drug candidates and to investigate their mechanism of action [29]. Mice were 
randomly divided into four groups (n = 3-4 each): normal group (Control), control 
colitis group (DSS), DSS fed three times/day 1 mg of MCs / 100 μL in 0.25% (v/v) 
acetic acid with Ge in order to reach a daily dose of 0.08 mg of Ge / mouse 
(DSS+MCGe group), and DSS fed three times / day 1 mg of empty MCs / 100 μL in 
0.25% (v/v) acetic acid (DSS+ empty MCs). Experiments were performed twice. 
Animals were examined daily and the Disease Activity Index (DAI) that combines 
weight loss, stool consistency and bleeding was calculated as described [30, 31]. On day 
10, animals were sacrificed and colon removed for further studies. 
 
2.12. Cytokines 
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Colon segments were homogenized as previously [30,31]; supernatants were stored at -
70°C for further analysis. Murine TNF- and MCP-1 (BD Biosciences), IL-6 and IL-10 
(BD Pharmingen) were evaluated with ELISA kits as specified by the manufacturers. 
 
2.13. Myeloperoxidase Assay 
Myeloperoxidase (MPO) activity was performed as previously [30,31]. Results were 
expressed in optical density/mg tissue. 
 
2.14. Superoxide dismutase activity 
SOD activity was determined as described previously [32]. Results were expressed as 
SOD units/mg protein (one SOD unit is the enzyme activity that inhibits 50% the NBT 
reduction).  
 
2.15. Malonaldehyde production 
Malonaldehyde production was determined as previously [32]. Results were expressed 
in µmoles of MDA/mg protein. 
 
2.16. Histopathological analysis 
Excised portions of the distal colon were fixed immediately in 4% w/v formaldehyde 
solution and embedded in paraffin. Next, 5 μm sections were mounted on glass slides, 
and deparaffinized. For histological analysis, slices were stained using standard H&E 
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techniques. Images were taken with a Nikon optical microscope (Nikon eclipse 
TE2000-U, USA). 
 
2.17. Statistical analysis 
Data were expressed as means ± SEM. Statistical differences between groups were 
determined by one-way analysis of variance followed by Tukey post-test. A value of 
p<0.05 was considered statistically significant. Multidimensional analysis was 
performed to assess inflammatory profiles within the various conditions studied. We 
performed standardization of 6 parameters (DAI, colon Length/Weight, IL-10, TNF-α, 
IL-6 and MCP-1), so that each parameter would contribute in similar manner to the final 
classification; mice with similar characteristics were grouped within clusters. Statistical 
analysis was performed using GraphPad Prism 4 software (GraphPad Software, San 
Diego, CA, USA) and Infostat version 2008 FCA UNC, Argentina [33].  
 
3. Results and Discussion 
3.1 Preparation and characterization of MCs 
Herein, we microencapsulated soy Ge using WSChitosan obtained by Maillard reaction 
as wall material, as we found previously that Chitosan derivatives kept functional 
properties of native polymer [20, 22]. Microencapsulation was performed by spray 
drying, an efficient and economical method [34] that has been successfully used with 
Chitosan as encapsulating material in food industry to protect several sensitive products 
[35, 36]. Morphology of MCs loaded with Ge (MCGe) assessed by SEM revealed 
predominantly spherical shape with a smooth surface (Fig. 1A and B). Collapsed aspect 
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was related to the intensive evaporation at the surface of each droplet, at the moment of 
mixing the air with the atomized liquid. Mean particle diameter was 2.62 µm (Fig. 1C), 
ranging from 1 to 4.63 µm [37].  
ME (%) performed by exhaustive extraction showed that 78±5% of total Ge content was 
inside the particle, supporting the suitability of the wall material selected [38]. For in 
vivo experiments, doses were calculated considering the total content, which was 
2.30±0.20% (w/w). Ge release in vitro followed a biphasic pattern, with an initial burst 
in simulated gastric conditions and a sustained release after 45.5 h under simulated 
intestinal conditions (Fig. 1D), indicating a release mechanism dependent on the pH. 
Data from Ge release in simulated gastrointestinal conditions were fitted with the 
Korsmeyer-Peppas equation (2). At pH 1.2, we found a release exponent (n) value of 
0.94 and a regression coefficient (R
2
) of 0.99, which matches with a super Case II 
transport type mechanism involving simultaneous contributions from dissolution, 
relaxation of the polymeric chain, erosion and swelling of Chitosan. During the first 4.5 
h at pH 6.8, MCs presented an anomalous non-Fickian transport with R2 and n value of 
0.96 and 0.67, respectively, corresponding to coupled diffusion/polymer relaxation, as 
described for indomethacin release from Chitosan-nanoparticles [39] or MCs of alginate 
and 0.25% Chitosan [40]. Under extended simulated intestinal conditions, a sustained 
release was observed, with a maximum value of 40%. In this way, although the sudden 
release of Ge allowed to reach quickly an effective concentration, the prolonged release 
promoted a sustained concentration of Ge in the effective range. 
To evaluate free radical scavenging activity (SA), a comparative analysis was made 
between pure Ge, Ge from MCs and Trolox as antioxidant control (Fig. 2). SA (%) of 
Ge from MCs was calculated as the difference between SA (%) of MCs with Ge and 
empty MCs (Fig. S1). From the slope ratio it can be deduced that empty MCs contribute 
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90% and 36% to the scavenging of O2
−
 and HO

 radicals, respectively. Similar results 
were shown in our previous work with MCs of WSChitosan derivative loaded with 
quercetin [22]. In terms of SA (%) of HO

 radical, both pure Ge and Ge from MCs 
reached a plateau at 5 µM; however Ge from MCs exhibited a slightly higher activity 
(Fig. 2A); for O2
−
 radical scavenging, Ge from MCs showed higher activity at all 
concentrations tested (Fig. 2B). We also calculated the Trolox equivalent antioxidant 
capacity (TEAC) for pure and MCGe (Fig. 2C); for both radicals, Ge from MCs 
presented higher TEAC values (µM), with 2 (for HO) and 1.5 (for O2
−
) fold more 
activity than pure Ge. This may be due to the fact that MCs are a controlled release 
system that allows the reposition of Ge in the medium. Chitosan has not always been 
considered an appropriate wall material; Kumar et al. reported that it was not able to 
protect squalene from oxidation during storage [40]. In our experimental condition, SA 
of Ge in MCs was preserved and the potency enhanced as well. The finding is relevant 
as Ge could be highly potent in TEAC assays but less potent in in vitro tests [41]. On 
the other hand, many natural compounds possess radical scavenging/antioxidative 
effects in cell-free systems but these results do not necessarily indicate activity against 
the oxidative stress in vivo [42]. 
 
3.2. Assessment of in vivo biodisponibility of MCs 
In the digestive system wall materials interact with the environment and their ability to 
sustain the cores allow controlled release of bioactives [43]. In agreement, Chitosan is 
widely selected for sustained-release preparations in the small intestine [44]. On the 
other hand, effective treatments of IBD require selective accumulation of therapeutic 
agents in the intestine. Here we evaluated the presence of MCs in luminal content of 
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mice fed MCs-FITC using flow cytometry. Fig. S2 shows our gate strategy (A) and 
fluorescent particles in the luminal content of different gut sections (B). After 4 h of 
feeding, fluorescent particles were detected mainly in the small gut (>90%) with only 
1% reaching the colon; in contrast 6 h after oral administration, around 30% of MCs-
FITC was found in the colon, a main target in IBD. No fluorescence was detected in the 
colon of mice fed unlabeled MCs (data not shown). Accordingly, using fluorescently-
labelled Chitosan–hypromellose MCs and multispectral small animal imaging, Ma et al. 
found higher colonic fluorescent intensity 8-24 h after oral administration, 
demonstrating the ‘guarding’ effect of Chitosan–hypromellose MCs during the transit 
along the gastrointestinal tract [45].  
 
3.3. MCGe attenuates inflammatory response in DSS-induced colitis 
Intestinal inflammation strongly correlates with oxidative stress; considering the 
sustained release of Ge in simulated intestinal environment (Fig. 1D), the strong 
antioxidant activity of MCGe (Fig. 2A and B) and the acceptable accumulation of MCs 
in colon after oral administration (Fig. S2B), we hypothesized that MCs could represent 
an efficient delivery platform of Ge for targeted treatment of intestinal inflammation. 
We used the acute murine model of DSS-colitis that recapitulates many clinical findings 
associated with human ulcerative colitis. As can be seen, mice treated with 3% DSS 
developed colitis on day 5, and progressively worsened until day 8, when they reached 
the highest DAI (Fig. 3); in contrast, daily oral administration of 0.08 mg Ge improved 
clinical signs and decreased DAI values. In agreement, natural antioxidants as 6-
gingerol, ascorbic acid and Sasa quelpaertensis leaf extracts were able to suppress 
induction of ulcerative colitis via antioxidant and anti-inflammatory activities [46-48]. 
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The administration of MCGe also prevented colon shortening induced by DSS (Fig. 
S3A and B). On day 10 colon sections of DSS group stained with H&E showed marked 
signs of inflammation, interstitial edema, epithelial erosion and abundant number of 
inflammatory cells in the lamina propria (Fig. 4B); with daily MCGe administration, 
histopathological signs were almost absent with lack of leukocyte infiltration (Fig. 4C), 
and tissue features similar to control group (Fig. 4A); in DSS+MCs mice, colon 
histoarchitecture was relatively conserved according to the weak inflammatory response 
found in this group (Fig. 4D). Interestingly, mice treated with empty MCs showed a 
mild protective effect on days 6-8, possibly related to the antioxidant and anti-
inflammatory bioactivities of WSChitosan derivatives [20, 22] and Chitosan itself [49]. 
Notably, MPO activity, a marker of neutrophil infiltration, augmented in DSS-induced 
colitis group (Fig. 4E) and was significantly reduced in MCGe and MCs mice with 
similar values to control group. The oral administration of both MCGe and MCs 
reduced significantly the production of pro-inflammatory cytokines IL-6 (Fig. 5A) and 
TNF- (Fig. 5B) and the chemokine MCP-1 (Fig. 5C), that regulates migration and 
infiltration of monocytes/macrophages. 
 
In terms of antioxidant actions in situ, SOD activity increased in colonic samples of 
DSS group (Fig. 6A); in striking contrast, mice treated with MCGe exhibited similar 
values to control group. Accordingly, supplementation of feeding diet with soy 
isoflavones reduced signs of colitis and exhibited antioxidant activity with increased 
expression of ZnCuSOD and glutathione peroxidases [50]. MCGe antioxidant ability 
was further confirmed by malonaldehyde (MDA) levels in tissue samples (Fig. 6B), 
where DSS+MCGe group presented similar values to control mice. Other reports have 
suggested that Ge has no effect in clinical signs of colitis while soy equol exacerbated 
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weight loss at the higher dose evaluated [51]. We found that non-encapsulated Ge was 
unable to mediate anti-oxidant and anti-inflammatory effects (Fig. S4); mice fed pure 
Ge developed severe colitis comparable to DSS group (A), with similar levels of MCP-
1 (B), MPO (C) and SOD (D) activities and leukocyte infiltration (E). Together, 
differences in delivery system and Ge dose could explain dissimilar results, since using 
a similar daily dose, we found that pure Ge had no beneficial effect on the inflammatory 
and oxidative responses elicited by DSS. Remarkably, these findings confirmed that 
microencapsulation efficiently preserved the biological properties of Ge. 
 
3.4. MCGe restores master regulatory cytokine in DSS-induced colitis 
As shown in Fig. 5D, MCGe stimulated the recovery of the master regulatory cytokine 
IL-10 to levels found in control group. Remarkably, the production of this key anti-
inflammatory mediator was a selective effect of MCs loaded with Ge, as IL-10 levels in 
mice fed empty MCs were similar to DSS group. This was an unexpected result as a diet 
with 600 mg Ge/kg alleviated DSS-caused colonic injury and improved tight junction 
protein expression in Caco cells without modifying IL-10 production [10]. To confirm 
the relevance of our finding we performed Principal Component Analysis (PCA) to 
describe the inflammatory status of treated (MCs+DSS and MCGe+DSS) and untreated 
(DSS and control) groups. We considered the following parameters: DAI, IL-10, TNF-
, IL-6, MCP-1, and Length/Weight of colon. As can be seen (Fig. 7A), Principal 
Components 1 (PC1) and 2 (PC2) explained 82.5% of total variability of the data; 
Analysis of each parameter showed that IL-10 was the variable with the highest 
influence on PC1 configuration for groups (data not shown); interestingly, control and 
DSS+MCGe mice that presented similar values of IL-10 in colonic tissue clustered 
together (Fig. 7A), supporting the recovery of this master regulator upon treatment with 
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Ge. In agreement, Zhikang Capsule, a traditional Chinese medicine widely used for IBD 
therapy, effectively promoted the production of IL-10, limited neutrophil influx and 
MPO activity and restored SOD and MDA to control values [52]. The minimal 
spanning tree (MST) depicted in Fig. 7B, where 100% of the data variability was taken 
into account, evidence the higher integration between control and DSS+MCGe mice, 
compared with DSS+MCs and DSS groups. Additionally, oxidative parameters (MPO 
and SOD activities and MDA production) were included in multivariate analysis and 
correlation coefficients were calculated (Fig. 7C). Interestingly, we found a negative 
correlation of IL-10 with all parameters studied that was significant with DAI and 
MCP-1 values. Accordingly, IL-10 interacts with the cellular machinery inhibiting ROS 
production, which in turn decreases NF-κB activity and the expression of inflammatory 
cytokines [53]. Moreover, in a model of S. japonicum infection, Ge decreased NF-κB 
signaling, and subsequently reduced MCP-1, TNF-α and IL-10 production [54]. The 
concept that IL-10 could act as an antioxidant blocking the release of ROS provides 
new pathways to understand the redox/oxidant perturbation during the evolution of 
inflammatory states. 
 
4. Conclusions 
Conventional therapies for treating IBD are usually associated with complications or 
side effects; therefore, development of safer therapeutic options is essential. Here we 
demonstrated that the delivery of Ge in MCs of WSChitosan produced drastic reduction 
of clinical parameters in DSS colitis, attenuating tissue injury and normalizing both 
inflammatory (IL-6, TNF-, MCP-1) and oxidative (SOD, MDA, MPO) markers.   
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Remarkably, only those mice treated with MCGe restored the production of IL-10 to 
homeostaic levels. The targeted effect involved both IL-10 and redox/oxidant axis. The 
pivotal role of IL-10 in MCGe mice was confirmed with multivariate analysis, where 
IL-10 turned out to be the variable with highest influence on PC1 configuration for 
control and MCGe groups. Together, our data show that the delivery platform of the 
isoflavone described here could be considered an interesting alternative for therapeutic 
approach to treat intestinal inflammatory conditions. 
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Figure Legends  
Figure 1. Morphology of MCGe and Ge release in gastrointestinal conditions. SEM 
microphotographs of spray-dried particles with Ge (acceleration voltage of 5 kV) (A 
and B). MCGe sizes (n=100) obtained with SEM (C). Released Ge in simulated 
gastrointestinal digestion assays (D). Results were expressed as means ± SEM. 
Experiments were made by duplicate.  
Figure 2. Scavenging activity of MCGe. Percent scavenging activity of radicals HO 
(A) and O2− (B) by MCGe (●), pure Ge () and trolox (■). Trolox equivalent 
antioxidant activity (TEAC) for radicals (C). Results were expressed as means ± SEM. 
Experiments were made by duplicate. Means with different letters, in the same column, 
are significantly different (p< 0.05). 
Figure 3. Clinical resolution of DSS-colitis after treatment with MCGe. Mice from 
DSS, DSS+MCGe and DSS+empty MCs groups received 3% DSS for 5 days and 
drinking water for the next 5 days; mice from MCGe and MCs groups were fed three 
times/day 75 µL of a 1 mg MCs suspension/100 µL in 0.25 % (v/v) acetic acid; the 
daily dose of Ge was 0.08 mg/mouse. Control groups received daily the same volume of 
0.25% acetic acid. All mice were evaluated daily during 10 days for clinical signs to 
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assess the Disease Activity Index (DAI); data are mean ± SEM (n = 3-4 animals/group). 
Experiments were made by duplicate. Different letters indicate significant differences 
between groups on the same day (p< 0.05). 
Figure 4. Histopathological analysis of colon after treatment with MCGe. Sections 
obtained on day 10 after colitis induction were stained with H&E. Representative 
microphotographs from control (A), DSS (B), DSS + MCGe (C) and DSS + empty MCs 
(D) groups. Magnification: 400x. Colonic myeloperoxidase (MPO) activity per mg of 
tissue (E). Data are mean  SEM (n= 3-4 animals per group). Experiments were made 
by duplicate. Different letters indicate significant differences between groups (p< 0.05). 
Figure 5. Cytokines in colon of mice with DSS colitis after MCGe treatment. 
Cytokines (IL-6, TNF-, MCP-1 and IL-10) were quantified by ELISA kits in tissue 
homogenates obtained at the end of the treatment (day 10).  Data are mean  SEM (n= 
3-4 animals/group). Experiments were made by duplicate. Different letters indicate 
significant differences between groups (p< 0.05). 
Figure 6. Oxidative stress in colon of mice with DSS colitis after MCGe treatment. 
Superoxide dismutase (SOD) activity (A) and malondialdehyde (MDA) (B) were 
evaluated in colon homogenates obtained at the end of the treatment (day 10). Data are 
mean  SEM (n=3-4 animals/group). Experiments were made by duplicate.  Different 
letters indicate significant differences between groups (p< 0.05). 
 
Figure 7. Exploration of data variability and clustering in Ge treated and treated 
mice. Principal component analysis bi-plot graphs. Each mouse is represented by a dot 
and each explanatory and clustering variable used in the analysis is represented by a 
line. Eigenvalues are shown in parentheses next to each component (A). Representation 
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of the minimal spanning tree (MST) on the bi-plot graph (B); Spearman correlation 
coefficients; underlined values have significant correlation (C); P<0.05). 
Supplementary Figure Legends 
Figure S1. Percent scavenging activity of radicals HO

 (A) and O2
−
 (B) by (○) 
empty MCs and (●) MCGe. 
Figure S2. Assessment of microcapsule biodisponibility in intestine. Mice (n=3) 
were fed 200 L of empty MCs unlabeled or labeled with FITC; 4 or 6 h later the whole 
intestine was removed and the luminal content free of debris from identical sections of 
small intestine (duodenum, jejunum and ileum) and colon was evaluated for flow 
cytometry in mice  from different groups. Gatting strategy (A); representative 
histograms were the proportion of fluorescent events in each section is depicted (B). 
Experiments were made by duplicate. 
Figure S3. Morphology and Lenght / Weight colon ratio in different experimental 
groups. A) Representative photographs of colon at the end of the treatment in Control, 
DSS, DSS+ MCGe and DSS+ MCs groups; B) Lenght / Weight colon ratio (B).  Data 
are mean ± SEM (n = 3-4 animals/group). Experiments were performed twice. Different 
letters indicate significant differences between groups (p< 0.05). 
Figure S4. Evaluation of clinical signs of DSS colitis after treatment with 
unencapsulated Ge. Mice from DSS and DSS+Ge groups received 3% DSS for 5 days 
and drinking water for the next 5 days; mice from Ge groups were fed three times/day 
75 µL of Ge in 0.25 % (v/v) acetic acid and the daily dose of Ge was 0.08 mg/mouse. 
Control groups received daily the same volume of 0.25% (v/v) acetic acid. All groups 
were evaluated daily during 10 days for clinical signs. Disease Activity Index (DAI) at 
the end of the treatment (A), MCP-1 level (B), colonic myeloperoxidase (MPO) 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
activity, (C) superoxide dismutase (SOD) activity (D) and representative H&E stained 
section (E). Data are mean  SEM (n= 3-4 animals/group). Experiments were made by 
duplicate. Different letters indicate significant differences between groups (p< 0.05). 
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Highlights. 
 We used a Chitosan soluble derivative to microencapsulate genistein. 
 Microcapsules preserved genistein biological properties and reached colon upon 
feeding. 
 Microencapsulated genistein reduced intestinal inflammation and tissue damage 
in mice. 
 The observed effects were dependent on IL-10 production. 
 Microencapsulated genistein could be incorporated in functional foods. 
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